Literature DB >> 17640893

Quantitative analyses reveal the importance of regulated Hdmx degradation for p53 activation.

Yunyuan V Wang1, Mark Wade, Eetsin Wong, Yao-Cheng Li, Luo Wei Rodewald, Geoffrey M Wahl.   

Abstract

P53 regulates numerous downstream targets to induce cell cycle arrest, senescence, apoptosis, and DNA repair in response to diverse stresses. Hdm2 and Hdmx are critical negative regulators of P53 because Hdm2 regulates P53 abundance, and both can antagonize P53 transactivation. Modest changes in Hdm2 or Hdmx abundance affect P53 regulation, yet quantitative information regarding their endogenous intracellular concentrations and subcellular distributions during a stress response are lacking. We analyzed these parameters in normal and cancer cells after DNA damage. Our data show that the nuclear abundance of Hdm2 and Hdmx relative to P53 limits P53 activity in cells growing in culture. Upon DNA damage, P53 nuclear abundance increases, whereas Hdm2 and Hdmx stability decreases, which greatly limits their ability to antagonize P53, regardless of their levels. These data indicate that the damage-activated switch in Hdm2 ubiquitin ligase preference from P53 to itself and Hdmx is central to P53 activation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17640893      PMCID: PMC1941475          DOI: 10.1073/pnas.0701497104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  47 in total

1.  Functional analysis of the roles of posttranslational modifications at the p53 C terminus in regulating p53 stability and activity.

Authors:  Lijin Feng; Tongxiang Lin; Hiroaki Uranishi; Wei Gu; Yang Xu
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

2.  MDMX: a novel p53-binding protein with some functional properties of MDM2.

Authors:  A Shvarts; W T Steegenga; N Riteco; T van Laar; P Dekker; M Bazuine; R C van Ham; W van der Houven van Oordt; G Hateboer; A J van der Eb; A G Jochemsen
Journal:  EMBO J       Date:  1996-10-01       Impact factor: 11.598

3.  The C-terminal lysines fine-tune P53 stress responses in a mouse model but are not required for stability control or transactivation.

Authors:  Kurt A Krummel; Crystal J Lee; Franck Toledo; Geoffrey M Wahl
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-08       Impact factor: 11.205

4.  Phosphorylation of Hdmx mediates its Hdm2- and ATM-dependent degradation in response to DNA damage.

Authors:  Yaron Pereg; Dganit Shkedy; Petra de Graaf; Erik Meulmeester; Marina Edelson-Averbukh; Mogjiborahman Salek; Sharon Biton; Amina F A S Teunisse; Wolf D Lehmann; Aart G Jochemsen; Yosef Shiloh
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-23       Impact factor: 11.205

5.  A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans.

Authors:  Gareth L Bond; Wenwei Hu; Elisabeth E Bond; Harlan Robins; Stuart G Lutzker; Nicoleta C Arva; Jill Bargonetti; Frank Bartel; Helge Taubert; Peter Wuerl; Kenan Onel; Linwah Yip; Shih-Jen Hwang; Louise C Strong; Guillermina Lozano; Arnold J Levine
Journal:  Cell       Date:  2004-11-24       Impact factor: 41.582

6.  Loss of HAUSP-mediated deubiquitination contributes to DNA damage-induced destabilization of Hdmx and Hdm2.

Authors:  Erik Meulmeester; Madelon M Maurice; Chris Boutell; Amina F A S Teunisse; Huib Ovaa; Tsion E Abraham; Roeland W Dirks; Aart G Jochemsen
Journal:  Mol Cell       Date:  2005-05-27       Impact factor: 17.970

7.  Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53.

Authors:  R Montes de Oca Luna; D S Wagner; G Lozano
Journal:  Nature       Date:  1995-11-09       Impact factor: 49.962

8.  Phosphorylation of p53 on key serines is dispensable for transcriptional activation and apoptosis.

Authors:  Thelma Thompson; Christian Tovar; Hong Yang; Daisy Carvajal; Binh T Vu; Qunli Xu; Geoffrey M Wahl; David C Heimbrook; Lyubomir T Vassilev
Journal:  J Biol Chem       Date:  2004-10-06       Impact factor: 5.157

9.  Allosteric activation of latent p53 tetramers.

Authors:  T R Hupp; D P Lane
Journal:  Curr Biol       Date:  1994-10-01       Impact factor: 10.834

Review 10.  The MDM2 gene amplification database.

Authors:  J Momand; D Jung; S Wilczynski; J Niland
Journal:  Nucleic Acids Res       Date:  1998-08-01       Impact factor: 16.971

View more
  59 in total

1.  MdmX is required for p53 interaction with and full induction of the Mdm2 promoter after cellular stress.

Authors:  Lynn Biderman; Masha V Poyurovsky; Yael Assia; James L Manley; Carol Prives
Journal:  Mol Cell Biol       Date:  2012-01-30       Impact factor: 4.272

2.  A stapled p53 helix overcomes HDMX-mediated suppression of p53.

Authors:  Federico Bernal; Mark Wade; Marina Godes; Tina N Davis; David G Whitehead; Andrew L Kung; Geoffrey M Wahl; Loren D Walensky
Journal:  Cancer Cell       Date:  2010-11-16       Impact factor: 31.743

Review 3.  The p53 orchestra: Mdm2 and Mdmx set the tone.

Authors:  Mark Wade; Yunyuan V Wang; Geoffrey M Wahl
Journal:  Trends Cell Biol       Date:  2010-02-19       Impact factor: 20.808

4.  Cancer-associated p53 tetramerization domain mutants: quantitative analysis reveals a low threshold for tumor suppressor inactivation.

Authors:  Rui Kamada; Takao Nomura; Carl W Anderson; Kazuyasu Sakaguchi
Journal:  J Biol Chem       Date:  2010-10-26       Impact factor: 5.157

5.  HDMX regulates p53 activity and confers chemoresistance to 3-bis(2-chloroethyl)-1-nitrosourea.

Authors:  Genglin Jin; Stephen Cook; Bo Cui; William C Chen; Stephen T Keir; Patrick Killela; Chunhui Di; Cathy A Payne; Simon G Gregory; Roger McLendon; Darell D Bigner; Hai Yan
Journal:  Neuro Oncol       Date:  2010-05-14       Impact factor: 12.300

6.  Absolute Amounts and Status of the Nrf2-Keap1-Cul3 Complex within Cells.

Authors:  Tatsuro Iso; Takafumi Suzuki; Liam Baird; Masayuki Yamamoto
Journal:  Mol Cell Biol       Date:  2016-11-28       Impact factor: 4.272

Review 7.  Targeting Mdm2 and Mdmx in cancer therapy: better living through medicinal chemistry?

Authors:  Mark Wade; Geoffrey M Wahl
Journal:  Mol Cancer Res       Date:  2009-01       Impact factor: 5.852

Review 8.  The expanding universe of p53 targets.

Authors:  Daniel Menendez; Alberto Inga; Michael A Resnick
Journal:  Nat Rev Cancer       Date:  2009-10       Impact factor: 60.716

9.  Mdm2 and Mdm4 loss regulates distinct p53 activities.

Authors:  Juan A Barboza; Tomoo Iwakuma; Tamara Terzian; Adel K El-Naggar; Guillermina Lozano
Journal:  Mol Cancer Res       Date:  2008-06       Impact factor: 5.852

10.  Guarding the guardian: Mdmx plays important roles in setting p53 basal activity and determining biological responses in vivo.

Authors:  Yunyuan V Wang; Mark Wade; Geoffrey M Wahl
Journal:  Cell Cycle       Date:  2009-11-06       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.